Salivary gland tumors represent a diverse group of neoplasms that account for approximately 3–6 % of head and neck tumors [1]. Among these, the parotid gland is the most frequently involved site, followed by the submandibular and minor salivary glands [2]. These tumors exhibit significant histopathologic heterogeneity, ranging from benign entities such as pleomorphic adenoma to aggressive malignancies including mucoepidermoid carcinoma and adenoid cystic carcinoma [3]. Given their wide spectrum …